India Pesticides Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

India Pesticides Ltd trades at ₹134, in a downtrend and 42 weeks into that stage. That is −15.7% against its own 200-day average. It sits at 6% of a 52-week range of ₹130 to ₹190. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (12 weeks and counting).

Today the stock is in a downtrend — week 42 of stage 4, confirmed. At ₹134 it trades −15.7% versus its 200-day average and sits at 6% of its 52-week range (₹130–₹190).

Against the market, two honest reads. Cumulative: over the last 5.2 years the stock moved −61% while the NIFTY 500 moved +67% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (12 weeks and counting; last ahead the week of 2026-06-25) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

India Pesticides Ltd trades at 14.3× P/E, about the cheapest it has ever traded. Its long-run median P/E is 23.9×, measured across 5.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 14.3× is about the cheapest it has ever traded, against a long-run median of 23.9× measured over 5.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +45.7% against a −37.5% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −16.5%/yr price move, ~−4.9%/yr came from earnings growth and ~−11.6 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, India Pesticides Ltd was paying for profit growth of about 7.2% a year. Profit itself has compounded −2.3% a year over the past 5 years. Today the market pays 14.3× P/E, the 1st percentile of its own 5-year range.

What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is above what this company has actually delivered. A multiple that looks low because earnings fell is not the same thing as a low bar to clear.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

India Pesticides Ltd reads as topping out on its fundamental arc. Topping out — profit and EPS growth have decelerated hard (profit growth +54.7% at its peak → +10.1% latest) while ROCE still reads 17.0%. The read is built from 8 quarters across 4 curves, on partial evidence.

Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

4-Factor Sector Score

52.9/100 — rank 7 of 24 in Pesticides/Agrochemicals · 81% evidence confidence

India Pesticides Ltd scores 52.9 out of 100 against the 24 companies it is compared with in Pesticides/Agrochemicals, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.1 + 13.7 + 14.1 + 5 = 52.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

India Pesticides Ltd reported ₹252 Cr of revenue in the Jun 26 quarter, −8.4% year on year. Over 5 years it has compounded at 10.2% a year. The last full year, FY26, came in at ₹1,057 Cr. The last four reported quarters add to ₹1,033 Cr.

FY26 revenue came in at ₹1,057 Cr (+27.5% on the year), capping 5 years at 10.2% compound. The latest quarter (Jun 26) printed ₹252 Cr, −8.4% year on year.

Pace check: the last four quarters averaged +19.4% growth against the decade's 10.2% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +17.0% over the last 4 quarters against +21.6%/yr over the last 8 — rolling over; TTM profit +10.1% vs +30.5%/yr — rolling over.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

India Pesticides Ltd's operating margin is 14.0% in the Jun 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 13.0% to 30.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 14.0%, −2.0 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 13.0%–30.0%.

🚨 Why the margin moved: operating margin went −2.3 pp year on year while gross margin went +5.8 pp — the loss came mostly from the gross line: input costs and pricing.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

India Pesticides Ltd earned ₹23.0 Cr of net profit in the Jun 26 quarter, −34.3% year on year. Full-year FY26 profit was ₹120 Cr. The 5-year compound rate is −2.3%. That is 9.1% of the quarter's revenue. The same quarter a year earlier earned ₹35.0 Cr.

Jun 26 profit was ₹23.0 Cr, −34.3% year on year. On the full year, FY26 printed ₹120 Cr (+46.3%), and the 5-year compound rate is −2.3%.

🚨 Why profit moved: revenue contributed −8.4% and the margin −2.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +18.4% vs revenue +19.4%. Profit and revenue are moving roughly in step.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 69% of India Pesticides Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY26 that was ₹62.0 Cr of operating cash against ₹120 Cr of profit. After ₹91.0 Cr of capital spending, ₹−29.0 Cr was left as free cash.

FY26: operating cash of ₹62.0 Cr against reported profit of ₹120 Cr, leaving free cash of ₹−29.0 Cr after ₹91.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 69% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

🚨 Why conversion sits at 69%: the cash cycle stretched 108 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: conversion is below par and the cash cycle has stretched 108 days — the next section's job is to find where the cash is stuck.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

India Pesticides Ltd's cash conversion cycle runs 224 days in FY26, up from 116 days in FY21. Capital spending ran ₹235 Cr over the last 3 years. At FY26 sales of ₹1,057 Cr each day of that cycle holds about ₹2.9 Cr, so roughly ₹649 Cr sits inside the business at any moment.

FY26: debtors at 124 days, inventory at 191 days — roughly 6.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 224 days, looser than FY21's 116.

The full loop: cash goes out to suppliers and production on day 0; stock waits 191 days to sell; customers pay about 124 days after that; and suppliers themselves are paid at 92 days — netting out to the 224-day cycle.

In money terms: at FY26 sales of ₹1,057 Cr, each day of the cycle holds about ₹2.9 Cr — so the 224-day loop keeps roughly ₹649 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹235 Cr over the last 3 fiscal years against ₹54.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹68.0 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

India Pesticides Ltd earns a ROCE of 17% in FY26. That is up from a trough of 11% in FY24. Return on invested capital clears the cost of that capital by −2.1 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 11.4% net margin on 0.79× asset turns.

FY26 ROCE is 17%, recovered from a FY24 trough of 11% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 11.4% net margin × 0.79× asset turns × 1.32× balance-sheet leverage ≈ 11.9% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 9.9% − 12.0% = a −2.1 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

India Pesticides Ltd carries total debt of ₹110 Cr against shareholder equity of ₹1,010 Cr as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.04 in FY22 to 0.11 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹110 Cr against shareholder equity of ₹1,010 Cr — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.04 (FY22) to 0.11 (FY26). The returns on this page are earned, not borrowed.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of India Pesticides Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved +0.0 points over the same window, to 63.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −0.1 points over 8 quarters to 0.2%; Promoters: +0.0 points over 8 quarters to 63.6%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

India Pesticides Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions